Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 148,735 | 165,232 | 138,743 | 116,676 | 117,942 |
| Cost of Goods | 10,135 | 9,327 | 6,539 | 7,358 | 9,104 |
| Gross Profit | 138,600 | 155,905 | 132,204 | 109,318 | 108,838 |
| Operating Expenses | 225,257 | 240,958 | 225,819 | 208,169 | 207,090 |
| Operating Income | -86,522 | -84,726 | -93,076 | -98,493 | -98,148 |
| Interest Expense | 23,514 | 22,502 | 21,802 | 22,559 | 19,159 |
| Other Income | -11,855 | -31,379 | -18,782 | 3,170 | -10,884 |
| Pre-tax Income | -121,891 | -138,607 | -133,660 | -117,882 | -128,191 |
| Income Tax | 4,835 | 4,658 | -36 | 488 | 451 |
| Net Income Continuous | -126,726 | -143,265 | -133,624 | -118,370 | -128,642 |
| Net Income | $-126,726 | $-143,265 | $-133,624 | $-118,370 | $-128,642 |
| EPS Basic Total Ops | -1.78 | -2.03 | -1.89 | -1.68 | -1.83 |
| EPS Basic Continuous Ops | -1.78 | -2.03 | -1.89 | -1.68 | -1.83 |
| EPS Diluted Total Ops | -1.78 | -2.03 | -1.89 | -1.68 | -1.83 |
| EPS Diluted Continuous Ops | -1.78 | -2.03 | -1.89 | -1.68 | -1.83 |
| EBITDA(a) | $-58,857 | $-64,197 | $-74,452 | $-81,763 | $-82,750 |